Bleichroeder Acquisition Corp. III (NASDAQ: BCCQU) completes $345M SPAC offering

Q: What did Bleichroeder Acquisition Corp. III (BCCQU) raise in its SPAC IPO?

Bleichroeder Acquisition Corp. III completed an IPO of 34,500,000 units at $10.00 per unit, including the full over-allotment, generating $345,000,000 in gross proceeds to fund its future business combination.

Q: How is the $345,000,000 from the BCCQU IPO being held?

A total of $345,000,000 , including up to $14,700,000 of deferred underwriting discount, was deposited into a U.S.-based trust account. These funds remain restricted until a business combination, shareholder redemptions, or SPAC liquidation.

Q: How long does Bleichroeder Acquisition Corp. III (BCCQU) have to complete a business combination?

BCCQU generally has 24 months from the closing of its IPO to complete an initial business combination. If it fails, public shares are subject to redemption from the trust account, subject to applicable law.

Filing Impact

(High)

Filing Sentiment

(Neutral)

Form Type

8-K

Rhea-AI Filing Summary

Bleichroeder Acquisition Corp. III, a Cayman Islands blank check company, completed its Nasdaq-listed initial public offering of 34,500,000 units, including the full over-allotment, at $10.00 per unit, generating $345,000,000 in gross proceeds. Each unit consists of one Class A ordinary share and one-fourth of one redeemable warrant, with each whole warrant exercisable at $11.50 per share.

The company also sold 8,500,000 private placement warrants at $1.00 each to its sponsor and underwriters. In total, $345,000,000, including up to $14,700,000 of deferred underwriting discount, was deposited into a U.S. trust account, to be released only upon completion of an initial business combination, specified shareholder redemptions, or liquidation if no business combination occurs within 24 months of the IPO closing.

Two independent directors, Clemence Rasigni and Christopher Kellen, joined the board and its audit and compensation committees, and the company adopted amended and restated Cayman Islands constitutional documents in connection with the IPO. The SPAC intends to target North American and European businesses in disruptive growth sectors.

Insights

SPAC raises $345M, fully funds trust to seek a target.

Bleichroeder Acquisition Corp. III completed a SPAC IPO of $345,000,000, including the full 4.5M-unit over-allotment, with all proceeds plus private placement warrant cash held in trust at $10.00 per unit.

The structure is conventional: public units with quarter-warrants at an exercise price of $11.50, sponsor and underwriter private warrants, and up to $14,700,000 of deferred underwriting discount contingent on a future business combination. Funds remain restricted until a deal closes, redemptions occur, or up to 24 months elapse.

For investors, the key next milestone is identification and announcement of an initial business combination within that 24-month window, when deal quality, sector focus on disruptive North American and European businesses, and redemption behavior will become central.

8-K Event Classification

6 items: 1.01, 3.02, 5.02, 5.03, 8.01, 9.01

6 items

Item 1.01 Entry into a Material Definitive Agreement Business

The company signed a significant contract such as a merger agreement, credit facility, or major partnership.

Item 3.02 Unregistered Sales of Equity Securities Securities

The company sold equity securities in a private placement or other unregistered transaction.

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers Governance

Key personnel changes including departures, elections, or appointments of directors and executive officers.

Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year Governance

The company amended its charter documents, bylaws, or changed its fiscal year.

Item 8.01 Other Events Other

Voluntary disclosure of events the company deems important to shareholders but not covered by other items.

Item 9.01 Financial Statements and Exhibits Exhibits

Financial statements, pro forma financial information, and exhibit attachments filed with this report.

Key Figures

IPO units sold: 34,500,000 units IPO price per unit: $10.00 per unit Gross IPO proceeds: $345,000,000 +5 more

8 metrics

IPO units sold 34,500,000 units Initial public offering, including full 4,500,000-unit over-allotment

IPO price per unit $10.00 per unit Public offering price for each unit

Gross IPO proceeds $345,000,000 Gross proceeds from sale of 34,500,000 units

Private placement warrants 8,500,000 warrants Aggregate Private Placement Warrants sold to sponsor and underwriters

Private placement price $1.00 per warrant Price per Private Placement Warrant

Trust account funding $345,000,000 Proceeds from IPO and private placement placed in trust, includes up to $14,700,000 deferred discount

Deferred underwriting discount $14,700,000 Portion of proceeds in trust earmarked as underwriter’s deferred discount

Business combination deadline 24 months Period from IPO closing to complete initial business combination

Key Terms

blank check company, over-allotment option, Private Placement Warrants, trust account, +2 more

6 terms

blank check company financial

"The Company is a blank check company formed for the purpose of effecting a merger"

A blank check company is a publicly listed shell that raises money from investors before naming a specific business to buy or merge with, similar to handing a cashier a signed check and asking them to fill in the payee later. It matters to investors because it offers a faster, often cheaper path for private firms to become public, but carries extra risk since returns depend on the organizers’ ability to find a good deal and on limited information about the future business.

over-allotment option financial

"includes 4,500,000 units issued pursuant to the exercise in full by the underwriters of their over-allotment option"

An over-allotment option is a special agreement that allows underwriters to sell more shares than initially planned if demand is high. Think of it like a retailer offering extra units of a popular product to meet additional customer interest. This option helps ensure the full sale is completed and can also give investors extra shares if they want more.

Private Placement Warrants financial

"completed the private sale of an aggregate of 8,500,000 warrants (the “Private Placement Warrants”)"

Private placement warrants are tradable coupons given directly to a limited group of investors that let the holder buy a company's shares at a fixed price before a set expiration date. They matter to investors because they can provide extra upside if the stock rises and give companies a way to raise money outside a public offering, but they also can increase the number of shares outstanding (dilution) and therefore affect share value and investor returns.

trust account financial

"was placed in a U.S.-based trust account maintained by Continental Stock Transfer & Trust Company"

A trust account is a special bank or brokerage account where assets are held and managed by a designated person or firm (the trustee) for the benefit of another person or group (the beneficiary). It matters to investors because it separates assets from personal or corporate funds, can protect assets, control how and when money is used, and may affect tax or legal rights—think of it as a locked drawer opened only under agreed rules.

deferred discount financial

"which amount includes up to $14,700,000 of the underwriter’s deferred discount"

amended and restated memorandum and articles of association regulatory

"filed its amended and restated memorandum and articles of association"

A document that replaces and combines a company’s core governing papers into a single, updated set of rules spelling out the company’s purpose, share structure, voting rights and how decisions are made. Think of it as rewriting and consolidating a household’s rulebook so everyone knows who controls what and how major choices are handled. Investors watch these changes because they can alter ownership rights, governance, dividend policy and takeover protections, affecting value and control.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Understanding 8-K Material Events →

Available on EDGAR 07/09/2026 - 11:35 PM Accepted by SEC EDGAR 07/08/2026 - 05:11 PM

FAQ

What did Bleichroeder Acquisition Corp. III (BCCQU) raise in its SPAC IPO?

Bleichroeder Acquisition Corp. III completed an IPO of 34,500,000 units at $10.00 per unit, including the full over-allotment, generating $345,000,000 in gross proceeds to fund its future business combination.

How is the $345,000,000 from the BCCQU IPO being held?

A total of $345,000,000, including up to $14,700,000 of deferred underwriting discount, was deposited into a U.S.-based trust account. These funds remain restricted until a business combination, shareholder redemptions, or SPAC liquidation.

What securities are included in BCCQU units and how do the warrants work?

Each BCCQU unit includes one Class A ordinary share and one-fourth of one redeemable warrant. Each whole warrant allows the holder to buy one Class A ordinary share at an exercise price of $11.50 per share.

What private placement did BCCQU complete alongside its IPO?

Simultaneously with the IPO closing, BCCQU sold an aggregate of 8,500,000 Private Placement Warrants at $1.00 each, with 5,000,000 purchased by the sponsor and 3,500,000 by the underwriters, raising additional warrant proceeds.

How long does Bleichroeder Acquisition Corp. III (BCCQU) have to complete a business combination?

BCCQU generally has 24 months from the closing of its IPO to complete an initial business combination. If it fails, public shares are subject to redemption from the trust account, subject to applicable law.

What sectors is BCCQU primarily targeting for its business combination?

BCCQU may pursue targets in any sector or region, but its primary focus is on North American and European businesses in disruptive growth sectors, including those being transformed by technology adoption.

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): July 6, 2026

Bleichroeder Acquisition Corp. III

(Exact name of registrant as specified in its charter)

Cayman Islands

001-43387

98-1931116

(State or other jurisdiction

of incorporation)

(Commission File Number)

(IRS Employer

Identification No.)

1345 Avenue of the Americas, Fl 47
New York, NY 10105

(Address of principal executive offices, including zip code)

Registrant’s telephone number, including area code: 212-984-3835

Not Applicable

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Units, each consisting of one Class A ordinary share and one-fourth of one redeemable warrant	BCCQU	The Nasdaq Stock Market LLC
Class A ordinary shares, par value $0.0001 per share	BCCQ	The Nasdaq Stock Market LLC
Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share	BCCQW	The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 1.01. Entry into a Material Definitive Agreement.

On July 8, 2026, Bleichroeder Acquisition Corp. III (the “Company”) consummated its initial public offering (“IPO”) of 34,500,000 units (the “Units”), including the full exercise by the underwriters of an option to purchase up to 4,500,000 Units at the offering price to cover over-allotments. The Units were sold at a price of $10.00 per Unit, generating gross proceeds to the Company of $345,000,000. Each Unit consists of one Class A ordinary share of the Company, par value $0.0001 per share (the “Class A Ordinary Shares”), and one-fourth of one redeemable warrant of the Company (each, a “Warrant”), with each whole Warrant entitling the holder thereof to purchase one Class A Ordinary Share for $11.50 per share.

In connection with the IPO, the Company entered into the following agreements, forms of which were previously filed as exhibits to the Company’s registration statement on Form S-1 (File No. 333-296923) for the IPO, initially filed with the U.S. Securities and Exchange Commission on June 18, 2026 (the “Registration Statement”):

●

An Underwriting Agreement, dated July 6, 2026, by and between the Company and Cohen & Company Capital Markets, a division of Cohen & Company Securities, LLC (“CCM”), as representative of the several underwriters, a copy of which is attached as Exhibit 1.1 hereto and incorporated herein by reference.

●

A Warrant Agreement, dated July 6, 2026, by and between the Company and Continental Stock Transfer & Trust Company, as warrant agent, a copy of which is attached as Exhibit 4.1 hereto and incorporated herein by reference.

●

A Letter Agreement, dated July 6, 2026, by and among the Company, its officers and directors and the Sponsor (as defined below), a copy of which is attached as Exhibit 10.1 hereto and incorporated herein by reference.

●

An Investment Management Trust Agreement, dated July 6, 2026, by and between the Company and Continental Stock Transfer & Trust Company, as trustee, a copy of which is attached as Exhibit 10.2 hereto and incorporated herein by reference.

●

A Registration Rights Agreement, dated July 6, 2026, by and among the Company and certain security holders, a copy of which is attached as Exhibit 10.3 hereto and incorporated herein by reference.

●

A Private Placement Warrants Purchase Agreement, dated July 6, 2026 (the “Sponsor Private Placement Warrants Purchase Agreement”), by and between the Company and Bleichroeder Sponsor 3 LLC, a Delaware limited liability company (the “Sponsor”), a copy of which is attached as Exhibit 10.4 hereto and incorporated herein by reference.

●

A Private Placement Warrants Purchase Agreement, dated July 6, 2026 (the “Underwriter Private Placement Warrants Purchase Agreement”), by and among the Company, CCM and Clear Street LLC (“CS” and together with CCM, the “Underwriters”), a copy of which is attached as Exhibit 10.5 hereto and incorporated herein by reference.

●

Indemnity Agreements, dated July 6, 2026, by and among the Company and each director and executive officer of the Company, a form of which is attached as Exhibit 10.6 hereto and incorporated herein by reference.

●

A Services and Indemnification Agreement, dated July 6, 2026, by and among the Company, the Sponsor and Bleichroeder LP, a copy of which is attached as Exhibit 10.7 hereto and incorporated herein by reference.

Item 3.02. Unregistered Sales of Equity Securities.

Simultaneously with the closing of the IPO, pursuant to the Sponsor Private Placement Warrants Purchase Agreement and the Underwriter Private Placement Warrants Purchase Agreement, the Company completed the private sale of an aggregate of 8,500,000 warrants (the “Private Placement Warrants”) to the Sponsor and the Underwriters at a price of $1.00 per Private Placement Warrant. Of those 8,500,000 Private Placement Warrants, our Sponsor purchased 5,000,000 Private Placement Warrants and the Underwriters purchased an aggregate of 3,500,000 Private Placement Warrants. The Private Placement Warrants (and underlying securities) are identical to the Units sold in the IPO, except as otherwise disclosed in the Registration Statement. No underwriting discounts or commissions were paid with respect to such sale. The issuance of the Private Placement Warrants was made pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act of 1933, as amended.

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On July 6, 2026, in connection with the IPO, Clemence Rasigni and Christopher Kellen were appointed to the Board of Directors of the Company (the “Board”). Each of Ms. Rasigni and Mr. Kellen was appointed to the Board’s Audit Committee, with Ms. Rasigni serving as chair. Each of Ms. Rasigni and Mr. Kellen was appointed to the Board’s Compensation Committee, with Mr. Kellen serving as chair.

On July 6, 2026, the Company entered into indemnity agreements with each of the directors and executive officers of the Company that require the Company to indemnify each of them to the fullest extent permitted by applicable law and to advance expenses incurred as a result of any proceeding against them as to which they could be indemnified. The foregoing summary of the indemnity agreements does not purport to be complete and is subject to, and qualified in its entirety by, the full text of the form of indemnity agreement, which is filed as Exhibit 10.6 to this Current Report on Form 8-K and incorporated herein by reference.

Item 5.03. Amendments to the Amended and Restated Memorandum and Articles of Association; Change in Fiscal Year.

On July 6, 2026, in connection with the IPO, the Company filed its amended and restated memorandum and articles of association (the “A&R Memorandum and Articles of Association”) with the Cayman Islands Registrar of Companies, which was effective on July 6, 2026. The terms of the A&R Memorandum and Articles of Association are set forth in the Registration Statement and are incorporated herein by reference. A copy of the A&R Memorandum and Articles of Association is attached as Exhibit 3.1 hereto and incorporated herein by reference.

Item 8.01. Other Events.

A total of $345,000,000 of the proceeds from the IPO and the sale of the Private Placement Warrants (which amount includes up to $14,700,000 of the underwriter’s deferred discount), was placed in a U.S.-based trust account maintained by Continental Stock Transfer & Trust Company, acting as trustee. Except with respect to interest earned on the funds in the trust account that may be released to the Company to pay its taxes and for winding up and dissolution expenses, the funds held in the trust account will not be released from the trust account until the earliest of (i) the completion of the Company’s initial business combination, (ii) the redemption of the Company’s public shares if it is unable to complete its initial business combination within 24 months from the closing of the IPO (or by such earlier liquidation date as the Board may approve), subject to applicable law, and (iii) the redemption of the Company’s public shares properly submitted in connection with a shareholder vote to amend the Company’s A&R Memorandum and Articles of Association to modify the substance or timing of its obligation to redeem 100% of the Company’s public shares if it has not consummated an initial business combination within 24 months from the closing of the IPO or with respect to any other material provisions relating to shareholders’ rights or pre-initial business combination activity.

On July 6, 2026, the Company issued a press release announcing the pricing of the IPO, a copy of which is attached as Exhibit 99.1 to this Current Report on Form 8-K.

On July 8, 2026, the Company issued a press release announcing the closing of the IPO, a copy of which is attached as Exhibit 99.2 to this Current Report on Form 8-K.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

The following exhibits are being filed herewith:

Exhibit No.		Description
1.1		Underwriting Agreement, dated July 6, 2026, by and between Bleichroeder Acquisition Corp. III and Cohen & Company Capital Markets, a division of Cohen & Company Securities, LLC, as representative of the several underwriters.
3.1		Amended and Restated Memorandum and Articles of Association of Bleichroeder Acquisition Corp. III.
4.1		Warrant Agreement, dated July 6, 2026, by and between Bleichroeder Acquisition Corp. III and Continental Stock Transfer & Trust Company, as warrant agent.
10.1		Letter Agreement, dated July 6, 2026, by and among Bleichroeder Acquisition Corp. III, Bleichroeder Sponsor 3 LLC and each of the officers and directors of Bleichroeder Acquisition Corp. III.
10.2		Investment Management Trust Agreement, July 6, 2026, by and between Bleichroeder Acquisition Corp. III and Continental Stock Transfer & Trust Company, as trustee.
10.3		Registration Rights Agreement, dated July 6, 2026, by and among Bleichroeder Acquisition Corp. III, Bleichroeder Sponsor 3 LLC and certain security holders.
10.4		Private Placement Warrants Purchase Agreement, dated July 6, 2026, by and between Bleichroeder Acquisition Corp. III and Bleichroeder Sponsor 3 LLC.
10.5		Private Placement Warrants Purchase Agreement, dated July 6, 2026, by and among Bleichroeder Acquisition Corp. III, Cohen & Company Capital Markets, a division of Cohen & Company Securities, LLC, and Clear Street LLC.
10.6		Form of Indemnity Agreement (incorporated herein by reference to Exhibit 10.6 to the Registration Statement on Form S-1 (File No. 333-296923), filed by Bleichroeder Acquisition Corp. III on June 18, 2026).
10.7		Services and Indemnification Agreement, dated July 6, 2026, by and among Bleichroeder Acquisition Corp. III, Bleichroeder Sponsor 3 LLC and Bleichroeder LP
99.1		Pricing Press Release, dated July 6, 2026.
99.2		Closing Press Release, dated July 8, 2026.
104		Cover Page Interactive Data File (embedded within the Inline XBRL document).

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: July 8, 2026	BLEICHROEDER ACQUISITION CORP. III

	By:	/s/ Marcello Padula
	Name:	Marcello Padula
	Title:	Chief Executive Officer

Exhibit 99.1

Bleichroeder Acquisition Corp. III Announces the Pricing of $300,000,000 Initial Public Offering

NEW YORK, NY, July 6, 2026 -- Bleichroeder Acquisition Corp. III (the “Company”) announced today the pricing of its initial public offering of 30,000,000 units. The units are expected to be listed on The Nasdaq Stock Global Market (“Nasdaq”) and begin trading tomorrow, July 7, 2026, under the ticker symbol “BCCQU.” Each unit consists of one Class A ordinary share of the Company and one-fourth of one redeemable warrant. Each whole warrant entitles the holder thereof to purchase one Class A ordinary share at a price of $11.50 per share. Once the securities constituting the units begin separate trading, the Class A ordinary shares and warrants are expected to be listed on Nasdaq under the symbols “BCCQ” and “BCCQW,” respectively. The offering is expected to close on July 8, 2026, subject to customary closing conditions. The Company has granted the underwriters a 45-day option to purchase up to an additional 4,500,000 units at the initial public offering price to cover over-allotments, if any.

The Company is a blank check company formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The Company may pursue an acquisition opportunity in any industry, sector or geographic region. The Company’s primary focus, however, will be on North American and European businesses in disruptive growth sectors, which may include companies within sectors that are being transformed via technology adoption. The Company’s management team is led by its Co-Founders, Michel Combes and Andrew Gundlach, Marcello Padula, its Chief Executive Officer, and Robert Folino, its Chief Financial Officer. The Board also includes Clemence Rasigni and Christopher Kellen.

Cohen & Company Capital Markets is acting as Lead Book-Running Manager for the offering.

The offering is being made only by means of a prospectus. When available, copies of the prospectus may be obtained from Cohen & Company Capital Markets, a division of Cohen & Company Securities, LLC, 3 Columbus Circle, 24th Floor, New York, NY 10019, Attention: Prospectus Department, or by email at: capitalmarkets@cohencm.com.

A registration statement relating to the securities has been filed with the U.S. Securities and Exchange Commission (the “SEC”) and became effective on July 6, 2026. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

Forward-Looking Statements

This press release contains statements that constitute “forward-looking statements,” including with respect to the proposed initial public offering. No assurance can be given that the offering discussed above will be completed on the terms described, or at all.

Forward-looking statements are subject to numerous conditions, many of which are beyond the control of the Company, including those set forth in the “Risk Factors” section of the Company’s registration statement and prospectus for the Company’s initial public offering filed with the SEC. Copies of these documents are available on the SEC’s website, www.sec.gov. The Company undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.

Company Contact:

Bleichroeder Acquisition Corp. III

1345 Avenue of the Americas, 47th Floor New York, NY 10105

Attn: Robert Folino

(o) 212.984.3835

robert.folino@bspac1.com

Exhibit 99.2

Bleichroeder Acquisition Corp. III Completes $345,000,000 Initial Public Offering

NEW YORK, NY, July 8, 2026 -- Bleichroeder Acquisition Corp. III (the “Company”) announced today the closing of its initial public offering of 34,500,000 units, which includes 4,500,000 units issued pursuant to the exercise in full by the underwriters of their over-allotment option. The offering was priced at $10.00 per unit, resulting in gross proceeds of $345,000,000.

The Company’s units began trading on July 7, 2026 on The Nasdaq Global Market (“Nasdaq”) under the ticker symbol “BCCQU.” Each unit consists of one Class A ordinary share of the Company and one-fourth of one redeemable warrant. Each whole warrant entitles the holder thereof to purchase one Class A ordinary share at a price of $11.50 per share. Once the securities constituting the units begin separate trading, the Class A ordinary shares and warrants are expected to be listed on Nasdaq under the symbols “BCCQ” and “BCCQW,” respectively.

Of the proceeds received from the consummation of the initial public offering (including the exercise in full of the over-allotment option) and a simultaneous private placement of warrants, $345,000,000 (or $10.00 per unit sold in the offering) was placed in a trust account of the Company.

Cohen & Company Capital Markets acted as Lead Book-Running Manager for the offering.

The offering was made by means of a prospectus. Copies of the prospectus may be obtained from Cohen & Company Capital Markets, a division of Cohen & Company Securities, LLC, 3 Columbus Circle, 24th Floor, New York, NY 10019, Attention: Prospectus Department, or by email at: capitalmarkets@cohencm.com.

A registration statement relating to the securities was declared effective by the U.S. Securities and Exchange Commission (the “SEC”) on July 6, 2026. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

Forward-Looking Statements

This press release contains statements that constitute “forward-looking statements,” including with respect to the proposed initial public offering and the anticipated use of the net proceeds thereof. No assurance can be given that the net proceeds of the offering will be used as indicated. Forward-looking statements are subject to numerous conditions, many of which are beyond the control of the Company, including those set forth in the Risk Factors section of the Company’s registration statement and prospectus for the Company’s initial public offering filed with the SEC. Copies of these documents are available on the SEC’s website, www.sec.gov. The Company undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.

Company Contact:

Bleichroeder Acquisition Corp. III
1345 Avenue of the Americas, 47th Floor New York, NY 10105
Attn: Robert Folino
(o) 212.984.3835
robert.folino@bspac1.com

Bleichroeder Acquisition Corp. III (NASDAQ: BCCQU) completes $345M SPAC offering

Rhea-AI Filing Summary

Positive

Negative